Drug Screening Manufacturers Technological Advancements, Revenue Diversification, Patent Expansions, Cross-border Expansion, Performance Gap Identification, Organizational Growth Plans, Operational Excellence

Drug Screening Key Players and their Developments

The global drug screening market size was estimated at US$ 6.15 billion in 2023 and is projected to grow to US$ 10.34 billion by 2034, rising at a compound annual growth rate (CAGR) of 4.84% from 2024 to 2034.

Top Companies in the Drug Screening Market

• Cordant Health Solutions
• Sciteck, Inc.
• CareHealth America
• Clinical Reference Laboratory, Inc.
• Laboratory Corporation of America Holdings
• Agilent Technologies, Inc.
• ACM Global Laboratories.
• Bio-Rad Laboratories, Inc.
• Siemens Healthcare GmbH
• American Bio Medica Corporation
• Thermo Fisher Scientific, Inc.
• Alere Inc.
• Quidel Corporation
• Synergy Health plc.
• F. Hoffmann-La Roche Ltd.
• Abbott
• Shimadzu Medical Pvt. Ltd.
• Quest Diagnostics Incorporated
• BioMerieux SA
• Express Diagnostics Int’l, Inc.
• Biomedical Diagnostics
• Danaher

Recent Announcements by Industry Leaders

In January 2024, Micro-Distributing, Inc. and ABK Remote Drug Testing, Inc., the owners of eRAMxTM Live Remote Drug Testing, have announced the establishment of a strategic partnership. The businesses will provide the first and only live, 24/7 remote drug testing service in the U.S.

Recent Developments in the Drug Screening Market

• In October 2024, Broughton introduced the most recent edition of Tox HQ, an online data-driven application that enables clients to discreetly submit their goods for toxicological evaluation in an effort to streamline the toxicity assessment, testing, and regulatory consulting processes.
• In October 2024, Beijing-based ICE Bioscience and SPT Labtech established a collaborative lab devoted to advancements in life sciences automation and intelligent drug screening.